Literature DB >> 24038029

Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.

Emanuela Ferru1, Antonella Pantaleo, Franco Carta, Franca Mannu, Amina Khadjavi, Valentina Gallo, Luisa Ronzoni, Giovanna Graziadei, Maria Domenica Cappellini, Francesco Turrini.   

Abstract

High counts of circulating microparticles, originated from the membrane of abnormal erythrocytes, have been associated with increased thrombotic risk in hemolytic disorders. Our studies indicate that in thalassemia intermedia patients the number of circulating microparticles correlates with the capability of the thalassemic erythrocytes to release microparticles. The microparticles are characteristically loaded with hemichromes formed by denatured α-chains. This finding was substantiated by the positive correlation observed in thalassemia intermedia patients between the amount of hemichromes measured in erythrocytes, their capability to release microparticles and the levels of plasma hemichromes. We observed that hemichromes, following their binding to the cytoplasmic domain of band 3, induce the formation of disulfide band 3 dimers that are subsequently phosphorylated by p72Syk kinase. Phosphorylation of oxidized band 3 appears to be relevant for the formation of large hemichromes/band 3 clusters that, in turn, induce local membrane instability and the release of microparticles. Proteomic analysis of microparticles released from thalassemia intermedia erythrocytes indicated that, besides hemichromes and clustered band 3, the microparticles contain a characteristic set of proteins that includes catalase, heat shock protein 70, peroxiredoxin 2 and carbonic anhydrase. High amounts of immunoglobulins and C3 have also been found to be associated with microparticles, accounting for their intense phagocytosis. The effect of p72Syk kinase inhibitors on the release of microparticles from thalassemia intermedia erythrocytes may indicate new perspectives for controlling the release of circulating microparticles in hemolytic anemias.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24038029      PMCID: PMC3943323          DOI: 10.3324/haematol.2013.084533

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  49 in total

1.  Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin.

Authors:  Ulrich Salzer; Rong Zhu; Marleen Luten; Hirotaka Isobe; Vassili Pastushenko; Thomas Perkmann; Peter Hinterdorfer; Giel J C G M Bosman
Journal:  Transfusion       Date:  2007-12-07       Impact factor: 3.157

Review 2.  Thalassemia intermedia: revisited.

Authors:  Ali Taher; Hussain Isma'eel; Maria D Cappellini
Journal:  Blood Cells Mol Dis       Date:  2006-06-05       Impact factor: 3.039

3.  Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.

Authors:  Ali Taher; Hussain Isma'eel; Ghassan Mehio; Daniela Bignamini; Antonis Kattamis; Eliezer A Rachmilewitz; Maria Domenica Cappellini
Journal:  Thromb Haemost       Date:  2006-10       Impact factor: 5.249

4.  In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: a consequence of splenectomy.

Authors:  Vichai Atichartakarn; Pantep Angchaisuksiri; Katcharin Aryurachai; Suporn Chuncharunee; Ammarin Thakkinstian
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

5.  Endothelium-derived microparticles impair endothelial function in vitro.

Authors:  Sergey V Brodsky; Fan Zhang; Alberto Nasjletti; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05       Impact factor: 4.733

6.  Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice.

Authors:  M Estela Campanella; Haiyan Chu; Nancy J Wandersee; Luanne L Peters; Narla Mohandas; Diana M Gilligan; Philip S Low
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

7.  Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy.

Authors:  Maxwell Westerman; Arnold Pizzey; Jocelyn Hirschman; Mario Cerino; Yonit Weil-Weiner; Prya Ramotar; Ada Eze; Andrew Lawrie; Gordon Purdy; Ian Mackie; John Porter
Journal:  Br J Haematol       Date:  2008-04-17       Impact factor: 6.998

8.  Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression.

Authors:  Sophie Martin; Angela Tesse; Bénédicte Hugel; M Carmen Martínez; Olivier Morel; Jean-Marie Freyssinet; Ramaroson Andriantsitohaina
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

9.  Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients.

Authors:  C L Harteveld; C Refaldi; E Cassinerio; M D Cappellini; P C Giordano
Journal:  Blood Cells Mol Dis       Date:  2008-01-14       Impact factor: 3.039

Review 10.  Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions.

Authors:  Antonella Pantaleo; Giuliana Giribaldi; Franca Mannu; Paolo Arese; Franco Turrini
Journal:  Autoimmun Rev       Date:  2008-04-21       Impact factor: 9.754

View more
  23 in total

1.  Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.

Authors:  Claudia R Morris; Hae-Young Kim; Elizabeth S Klings; John Wood; John B Porter; Felicia Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Kathryn Hassell; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Sandra Larkin; Jung H Suh; Elliott P Vichinsky; Frans A Kuypers
Journal:  Br J Haematol       Date:  2015-04-24       Impact factor: 6.998

Review 2.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

3.  Quantitative proteomics of plasma vesicles identify novel biomarkers for hemoglobin E/β-thalassemic patients.

Authors:  Janejira Kittivorapart; Vanja Karamatic Crew; Marieangela C Wilson; Kate J Heesom; Noppadol Siritanaratkul; Ashley M Toye
Journal:  Blood Adv       Date:  2018-01-23

4.  Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.

Authors:  Panae Noomuna; Mary Risinger; Sitong Zhou; Katie Seu; Yuncheng Man; Ran An; Daniel A Sheik; Jiandi Wan; Jane A Little; Umut A Gurkan; Francesco M Turrini; Theodosia Kalfa; Philip S Low
Journal:  Br J Haematol       Date:  2020-04-28       Impact factor: 6.998

5.  Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.

Authors:  Anyapat Atipimonpat; Panjaree Siwaponanan; Archrob Khuhapinant; Saovaros Svasti; Kasama Sukapirom; Ladawan Khowawisetsut; Kovit Pattanapanyasat
Journal:  Ann Hematol       Date:  2021-06-21       Impact factor: 3.673

6.  Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles.

Authors:  Sirsendu Jana; Michael Brad Strader; Fantao Meng; Wayne Hicks; Tigist Kassa; Ivan Tarandovskiy; Silvia De Paoli; Jan Simak; Michael R Heaven; John D Belcher; Gregory M Vercellotti; Abdu I Alayash
Journal:  JCI Insight       Date:  2018-11-02

Review 7.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822

Review 8.  Neuroacanthocytosis: Observations, Theories and Perspectives on the Origin and Significance of Acanthocytes.

Authors:  Merel J W Adjobo-Hermans; Judith C A Cluitmans; Giel J C G M Bosman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-08-25

9.  Extracellular vesicles in hematological disorders.

Authors:  Anat Aharon; Annie Rebibo-Sabbah; Inna Tzoran; Carina Levin
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

10.  Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress.

Authors:  Antonella Pantaleo; Kristina R Kesely; Maria Carmina Pau; Ioannis Tsamesidis; Evelin Schwarzer; Oleksii A Skorokhod; Huynh D Chien; Marta Ponzi; Lucia Bertuccini; Philip S Low; Francesco M Turrini
Journal:  Blood       Date:  2017-06-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.